- Issuer ticker
-
AMRX
- Reported as of
-
17 Sep 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
21 Sep 2026, 16:33:26 UTC
Filing notes and source
Key filing fact
J. Kevin Buchi filed Form 4 for Amneal Pharmaceuticals, Inc. (AMRX) on 21 Sep 2026.
Key facts
- This page summarizes J. Kevin Buchi's Form 4 filing for Amneal Pharmaceuticals, Inc. (AMRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2026, 16:33.
Change
- Previous filing in this sequence was filed on 14 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001209726
Primary reporting owner
BUCHI J KEVIN
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMRX
transaction
Class A Common Stock
Gift
- Transaction value
- Shares
- -20,445
- Change %
- -21%
- Price
-
$0.000000*
- Shares after
- 75,077
- Date
- 17 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
AMRX
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 113,944
- Date
- 17 Sep 2026
- Ownership
- By Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote